compounded semaglutide fda warning november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA and Novo Nordisk Warned

A basic one-a-day is not always enough

This means the molecule is designed to activate three metabolic hormone systems simultaneously: GLP-1 signaling associated with appetite and glucose response pathways GIP signaling connected to insulin signaling and nutrient metabolism Glucagon signaling linked to energy mobilization and metabolic flexibility By activating these three hormone pathways at the same time, researchers may observe complex metabolic signaling interactions that cannot be produced by single-receptor compounds

Sudden discontinuation can lead to more pronounced withdrawal effects, including rapid changes in appetite, blood glucose levels, and overall wellbeing

Make sure you and your provider agree on the format, and understand that injectable formats have stronger clinical evidence than oral compounded versions

Oat has been demonstrated to be a possible preventative agent for intestinal dysfunction, cancer, celiac disease, obesity, and other disorders

Semaglutide Reconstitution & Dose Math Compounded semaglutide is supplied as a lyophilized powder in 2 mg, 3 mg, 5 mg, 10 mg, or 15 mg vials